Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Direxion Daily S&P Biotech Bull 3X Shares LABU
$6.50
-$0.3 (-4.63%)
На 18:00, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
13.19
-
week52low
4.06
-
Revenue
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
0.00000000
-
Last Dividend
0.50600000
-
Next Earnings Date
07 мая 2023 г. в 01:21
Описание компании
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Top Performing Leveraged/Inverse ETFs: 05/07/2023
ETF Trends
10 мая 2023 г. в 16:43
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
5 Leveraged/Inverse ETFs That Gained Double Digits in April
Zacks Investment Research
02 мая 2023 г. в 12:57
The month of April was marked by huge volatility. Though recession fears continued to weigh on investors sentiment, cooling inflation and better-than-expected earnings drove the stocks higher.
5 Best Inverse/Leveraged ETFs of Last Week
Zacks Investment Research
25 апр 2023 г. в 09:09
Wall Street offered a flat performance last week.
Leveraged Biotech ETFs: Hold LABU, Sell LABD
Seeking Alpha
19 апр 2023 г. в 14:13
SPDR® S&P Biotech ETF, the Biotechnology Select Industry Index ETF, has an extreme short interest of 51.16%. XBI is in an uptrend since May-June 2022. Direxion Daily S&P Biotech Bull 3X Shares ETF, the 3X leveraged Biotech ETF, is rated as a HOLD.
Want Diversified Upside in Biotechnology? Check out LABU
MarketBeat
22 мар 2023 г. в 09:01
Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. This ETF attempts to mimic 3X the one-day performance of the SPDR S&P 500 Biotech ETF (NYSE: XBI).